Filter posts

New Infographic Highlights the Remarkable Success of Medicare Part D

Since 2006, the Medicare prescription drug program – known as Medicare Part D – has …

Pharmacy Revenues Decline, Thanks to Cheaper Medicines

We’ve been saying it for some time, and the numbers speak for themselves: spending on …

For Health Insurers, Business is Booming. But at Whose Expense?

Good news for the health insurance industry: business is booming – insurer stock prices soared …

Steps to Improve Competition in the Prescription Drug Marketplace

Recently on BIOtechNOW, we shared Three Encouraging Steps on Prescription Drug Costs which looked at recent …

The Risky Business of Drug Importation

You hear it all the time: prescription drugs in the United States are too expensive, …

Biomedical Innovation Can Help Solve the Opioid Crisis

Opioid abuse in America touches the lives of millions. It’s estimated that more than 1,000 …

ICYMI: Reducing Regulatory Hurdles Can Help Boost Innovation

Featured this week in the Wall Street Journal, columnist Greg Ip discusses how reducing regulatory hurdles …

What's Driving Health Care Spending? Hint: Not Drug Costs.

With health care costs an important concern for many Americans, a common misperception is the …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …